Quote: The author is and MD. "Is COVID Now Becoming a Pandemic of the Vaccinated? American
corporate media love catchphrases that they all repeat in unison,
across network and cable television and through social media. One recent
example is “viral blizzard” referring to the omicron variant of COVID. A
search of Google News for “viral blizzard” demonstrates how in the past
several days, myriad media outlets used the term in scaremongering
headlines.
Another similar phrase made the rounds this past summer, “pandemic of the unvaccinated,” attributed to
CDC Director Dr. Rochelle Walensky. At the time, it was believed that
only the unvaccinated were transmitting, catching, and getting sick from
COVID.
The same CDC Director Dr. Walensky two weeks later acknowledged, “vaccinated people infected with Delta can transmit the virus.” This lead to the July 27 CDC recommendation,
“that everyone wear a mask in indoor public settings in areas of
substantial and high transmission, regardless of vaccination status.” So
much for it being a pandemic of the unvaccinated. This is the time when
I must add this standard and necessary disclaimer that I am not
anti-vaccine, having been personally vaccinated. Nor am I offering
medical advice, only an analysis of this newsworthy issue with questions
about ever-changing recommendations and certainties from the political
and medical establishments. I am not the only one questioning this catchphrase. A German doctor wrote a letter to the prestigious medical journal The Lancet one month ago entitled, “COVID-19: stigmatizing the unvaccinated is not justified.He raised the following points, There is increasing evidence that vaccinated individuals continue to have a relevant role in transmission. People
who are vaccinated have a lower risk of severe disease but are still a
relevant part of the pandemic. It is therefore wrong and dangerous to
speak of a pandemic of the unvaccinated. I
call on high-level officials and scientists to stop the inappropriate
stigmatization of unvaccinated people, who include our patients,
colleagues, and other fellow citizens, and to put extra effort into
bringing society together." There is more so read on. Is COVID Now Becoming a Pandemic of the Vaccinated? - American Thinker
The lies WHO, CDC, NIH, FDC and their Pharmaceutical partners have told us are massive. Quote: "Wash. University Study Defends Natural Immunity. The Attacks on Natural Immunity must STOP! New Study says it is what you want - NOT a Vaccine! If
you’ve had COVID-19, even a mild case, major congratulations to you as
you’ve more than likely got long-term immunity, according to a team of
researchers from Washington University School of Medicine. In fact,
you’re likely to be immune for life, as is the case with recovery from
many infectious agents — once you’ve had the disease and recovered,
you’re immune, most likely for life. The
evidence is strong and promising, and should be welcome and comforting
news to a public that has spent the last year, 2020, in a panic over
SARS-CoV-2. Increasingly evidence is showing that long-lasting immunity exists.
Initial Reports That COVID Immunity Was Fleeting Were Flawed. Seasonal
coronaviruses, some of which cause common colds, yield only short-lived
protective immunity, with reinfections occurring six to 12 months after
the previous infection. Early data on SARS-CoV-2 also found that
antibody titers declined rapidly in the first months after recovery from
COVID-19, leading some to speculate that protective immunity against
SARS-CoV-2 may also be short-lived. Senior
author of the study, Ali Ellebedy, Ph.D., an associate professor of
pathology and immunology at Washington University School of Medicine in
St. Louis, pointed out that this assumption is flawed, stating in a news
release: “Last
fall, there were reports that antibodies waned quickly after infection
with the virus that causes COVID-19, and mainstream media interpreted
that to mean that immunity was not long-lived. But that’s a
misinterpretation of the data. It’s normal for antibody levels to go
down after acute infection, but they don’t go down to zero; they
plateau.”
The
researchers found a biphasic pattern of antibody concentrations against
SARS-CoV-2, in which high antibody concentrations were found in the
acute immune response that occurred at the time of initial infection.
The
antibodies declined in the first months after infection, as should be
expected, then leveled off to about 10% to 20% of the maximum
concentration detected. In a commentary on the study, Andreas Radbruch
and Hyun-Dong Chang of the German Rheumatism Research Centre Berlin
explained: “This
is consistent with the expectation that 10–20% of the plasma cells in
an acute immune reaction become memory plasma cells, and is a clear
indication of a shift from antibody production by short-lived plasma
cells to antibody production by memory plasma cells. This is not
unexpected, given that immune memory to many viruses and vaccines is
stable over decades, if not for a lifetime.” When
a new infection occurs, cells called plasmablasts provide antibodies,
but when the virus is cleared, longer lasting memory B cells move in to
monitor blood for signs of reinfection. Bone
marrow plasma cells (BMPCs) also exist in bones, acting as “persistent
and essential sources of protective antibodies.” According to Ellebedy,
“A plasma cell is our life history, in terms of the pathogens we’ve been
exposed to,” and it’s in these long-lived BMPCs were immunity to
SARS-CoV-2 resides.
Long-Term Immunity Likely After COVID-19 Infection. For
the study, blood samples were collected from 77 people who had
recovered from COVID-19, about one month after the onset of symptoms;
most had experienced mild cases. Additional blood samples were collected
three more times at three-month intervals to track antibody production;
memory B cells and bone marrow were also collected from some of the
participants. Levels
of anti-SARS-CoV-2 spike protein (S) antibodies declined rapidly in the
first four months after infection, then slowed over the next seven
months. The most exciting part of the research is that, at both seven
months and 11 months after infection, most of the participants had BMPCs
that secreted antibodies specific for the spike protein encoded by
SARS-CoV-2. The
BMPCs were found in amounts similar to those found in people who had
been vaccinated against tetanus or diphtheria, which are considered to
provide long-lasting immunity.
“Overall, our data provide strong evidence that SARS-CoV-2
infection in humans robustly establishes the two arms of humoral immune
memory: long-lived BMPCs and memory B cells,” the researchers
noted. This is perhaps the best available evidence of long-lasting
immunity, Radbruch and Chang explained, because this immunological
memory is a distinct part of the immune system that’s essential to
long-term protection, beyond the initial immune response to the virus: “In
the memory phase of an immune response, B and T cells that are specific
for a virus are maintained in a state of dormancy, but are poised to
spring into action if they encounter the virus again or a vaccine that
represents it. These memory B and T cells arise from cells activated in
the initial immune reaction. The cells undergo changes to their
chromosomal DNA, termed epigenetic modifications, that enable them to
react rapidly to subsequent signs of infection and drive responses
geared to eliminating the disease-causing agent. B cells have a dual
role in immunity: they produce antibodies that can recognize viral
proteins, and they can present parts of these proteins to specific T
cells or develop into plasma cells that secrete antibodies in large
quantities.
About 25 years ago, it became evident that
plasma cells can become memory cells themselves, and can secrete
antibodies for long-lasting protection. Memory plasma cells can be
maintained for decades, if not a lifetime, in the bone marrow.”
In addition, in 2020 it was reported that people who had
recovered from SARS-CoV — a virus that is genetically closely related to
SARS-CoV-2 and belongs to the same viral species — maintained
significant levels of neutralizing antibodies at least 17 years after
initial infection. This also suggests that long-term immunity against
SARS-CoV-2 should be expected. Ellebedy even said the protection is
likely to continue “indefinitely”. Wash. University Study Defends Natural Immunity | We the People Convention | wethepeopleconvention.org
No comments:
Post a Comment